Premium
Oral lichenoid drug reaction by lithium in a patient with bipolar disorder
Author(s) -
Campisi G.,
Florena A. M.,
Franco V.,
Coccia E.,
Muzio L. Lo
Publication year - 2005
Publication title -
journal of oral pathology and medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.887
H-Index - 83
eISSN - 1600-0714
pISSN - 0904-2512
DOI - 10.1111/j.1600-0714.2004.00272.x
Subject(s) - oxcarbazepine , carbamazepine , bipolar disorder , mania , lithium (medication) , medicine , mood , depression (economics) , lamotrigine , drug , treatment of bipolar disorder , adverse effect , psychiatry , dermatology , pediatrics , gastroenterology , epilepsy , economics , macroeconomics
Bipolar disorder (BD) is a psychiatric disease characterized by recurrent and alternated episodes of depression and mania. For the treatment of BD, anticonvulsants drugs as lithium, carbamazepine and oxcarbazepine can be used. These drugs can be associated with potential adverse effects: weight gain, tremors, thyroid abnormalities, and cognitive, gastrointestinal, cardiac or dermatological problems. We describe a case of BD with oral lichenoid drug reaction probably because of the mood stabilizers.